Manav Kapoor

Manav Kapoor

Auto-generated profile, based on publicly available information

Manav Kapoor

Regeneron Genetics Center, Tarrytown, NY, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2024 in Nature
Verified
Journal Article
Open access
PDF file
KSKathie Y. Sun
Kathie Y. Sun
XBXiaodong Bai
Xiaodong Bai
SCSiying Chen
Siying Chen
SBSuying Bao
Suying Bao
CZChuanyi Zhang
Chuanyi Zhang
SBSuganthi Balasubramanian
Suganthi Balasubramanian
Rare coding variants that substantially affect function provide insights into the biology of a gene1–3. However, ascertaining the frequency of such variants requires large sample sizes4–8. Here we present a catalogue of human protein-coding variation, derived from exome sequencing of 983,578 individuals across diverse populations. In total, 23% of the Regeneron Genetics Center Million Exome (RGC-ME) data come from individuals of African, East Asian, Indigenous American, Middle Eastern and South Asian ancestry. The catalogue includes more than 10.4 million missense and 1.1 million predicted loss-of-function (pLOF) variants. We identify individuals with rare biallelic pLOF variants in 4,848 genes, 1,751 of which have not been previously reported. From precise quantitative estimates of selection against heterozygous loss of function (LOF), we identify 3,988 LOF-intolerant genes, including 86 that were previously assessed as tolerant and 1,153 that lack established disease annotation. We also define regions of missense depletion at high resolution. Notably, 1,482 genes have regions that are depleted of missense variants despite being tolerant of pLOF variants. Finally, we estimate that 3% of individuals have a clinically actionable genetic variant, and that 11,773 variants reported in ClinVar with unknown significance are likely to be deleterious cryptic splice sites. To facilitate variant interpretation and genetics-informed precision medicine, we make this resource of coding variation from the RGC-ME dataset publicly accessible through a variant allele frequency browser.

8 May 2020 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
EBEric Brenner
Eric Brenner
GTGayatri R Tiwari
Gayatri R Tiwari
MKManav Kapoor
Manav Kapoor
YLYunlong Liu
Yunlong Liu
ABAmy Brock
Amy Brock
DMDayne Mayfield
Dayne Mayfield
Alcoholism remains a prevalent health concern throughout the world. Previous studies have identified transcriptomic patterns in the brain associated with alcohol dependence in both humans and animal models. But none of these studies have systematically investigated expression within the unique cell types present in the brain. We utilized single nucleus RNA sequencing (snRNA-seq) to examine the transcriptomes of over 16 000 nuclei isolated from the prefrontal cortex of alcoholic and control individuals. Each nucleus was assigned to one of seven major cell types by unsupervised clustering. Cell type enrichment patterns varied greatly among neuroinflammatory-related genes, which are known to play roles in alcohol dependence and neurodegeneration. Differential expression analysis identified cell type-specific genes with altered expression in alcoholics. The largest number of differentially expressed genes (DEGs), including both protein-coding and non-coding, were detected in astrocytes, oligodendrocytes and microglia. To our knowledge, this is the first single cell transcriptome analysis of alcohol-associated gene expression in any species and the first such analysis in humans for any addictive substance. These findings greatly advance the understanding of transcriptomic changes in the brain of alcohol-dependent individuals.

21 September 2017 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
CCCarlos Cruchaga
Carlos Cruchaga
JDJorge Del-Aguila
Jorge Del-Aguila
BSBenjamin Saef
Benjamin Saef
KBKathleen Black
Kathleen Black
MFMaria Victoria Fernandez
Maria Victoria Fernandez
OHOscar Harari
Oscar Harari

14 February 2019 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MKManav Kapoor
Manav Kapoor
JWJen-Chyong Wang
Jen-Chyong Wang
SFSean P. Farris
Sean P. Farris
YLYunlong Liu
Yunlong Liu
JMJeanette McClintick
Jeanette McClintick
AGAlison Goate
Alison Goate
Alcohol exposure triggers changes in gene expression and biological pathways in human brain. We explored alterations in gene expression in the Pre-Frontal Cortex (PFC) of 65 alcoholics and 73 controls of European descent, and identified 129 genes that showed altered expression (FDR < 0.05) in subjects with alcohol dependence. Differentially expressed genes were enriched for pathways related to interferon signaling and Growth Arrest and DNA Damage-inducible 45 (GADD45) signaling. A coexpression module (thistle2) identified by weighted gene co-expression network analysis (WGCNA) was significantly correlated with alcohol dependence, alcohol consumption, and AUDIT scores. Genes in the thistle2 module were enriched with genes related to calcium signaling pathways and showed significant downregulation of these pathways, as well as enrichment for biological processes related to nicotine response and opioid signaling. A second module (brown4) showed significant upregulation of pathways related to immune signaling. Expression quantitative trait loci (eQTLs) for genes in the brown4 module were also enriched for genetic associations with alcohol dependence and alcohol consumption in large genome-wide studies included in the Psychiatric Genetic Consortium and the UK Biobank’s alcohol consumption dataset. By leveraging multi-omics data, this transcriptome analysis has identified genes and biological pathways that could provide insight for identifying therapeutic targets for alcohol dependence.

20 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MKManav Kapoor
Manav Kapoor
MCMichael J. Chao
Michael J. Chao
EJEmma Johnson
Emma Johnson
GNGloriia Novikova
Gloriia Novikova
DLDongbing Lai
Dongbing Lai
AGAlison Goate
Alison Goate
Identification of causal variants and genes underlying genome-wide association study (GWAS) loci is essential to understand the biology of alcohol use disorder (AUD) and drinks per week (DPW). Multi-omics integration approaches have shown potential for fine mapping complex loci to obtain biological insights to disease mechanisms. In this study, we use multi-omics approaches, to fine-map AUD and DPW associations at single SNP resolution to demonstrate that rs56030824 on chromosome 11 significantly reduces SPI1 mRNA expression in myeloid cells and lowers risk for AUD and DPW. Our analysis also identifies MAPT as a candidate causal gene specifically associated with DPW. Genes prioritized in this study show overlap with causal genes associated with neurodegenerative disorders. Multi-omics integration analyses highlight, genetic similarities and differences between alcohol intake and disordered drinking, suggesting molecular heterogeneity that might inform future targeted functional and cross-species studies.

23 April 2021 in Genes, Brain and Behavior
Verified
Journal Article
Open access
PDF file
RPRohan HC Palmer
Rohan HC Palmer
EJEmma Johnson
Emma Johnson
Hyejung WonHyejung Won
Hyejung Won
RPRenato Polimanti
Renato Polimanti
MKManav Kapoor
Manav Kapoor
RWRobert W. Williams
Robert W. Williams
The National Institute on Drug Abuse and Joint Institute for Biological Sciences at the Oak Ridge National Laboratory hosted a meeting attended by a diverse group of scientists with expertise in substance use disorders (SUDs), computational biology, and FAIR (Findability, Accessibility, Interoperability, and Reusability) data sharing. The meeting's objective was to discuss and evaluate better strategies to integrate genetic, epigenetic, and 'omics data across human and model organisms to achieve deeper mechanistic insight into SUDs. Specific topics were to (a) evaluate the current state of substance use genetics and genomics research and fundamental gaps, (b) identify opportunities and challenges of integration and sharing across species and data types, (c) identify current tools and resources for integration of genetic, epigenetic, and phenotypic data, (d) discuss steps and impediment related to data integration, and (e) outline future steps to support more effective collaboration—particularly between animal model research communities and human genetics and clinical research teams. This review summarizes key facets of this catalytic discussion with a focus on new opportunities and gaps in resources and knowledge on SUDs.